
Radiopharmaceutical Industry Update: Q4/Q1 (2024-2025)
In 2025, the U.S. radiopharmaceutical market is expected to see continued growth, driven by aging populations, advancements in theranostics, an increased demand for targeted cancer treatments and an expansion of applications beyond oncology. North America …